The Triangle's next biotech companies are already taking shape in university labs. This session brings six faculty scientists to the stage to present discoveries at the frontier of venture formation — giving investors an early look at the human health innovations poised to anchor the Triangle's next wave of biotech companies.
We are excited to host an invite-only Tech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow tech investors over lunch and engage in insightful conversations. Thank you to KPMG for sponsoring this lunch!
The question is no longer whether AI will reshape your workforce. It already has. The harder question, and one most organizations have yet to solve is: how do you intentionally design how humans and AI work together to maximize value? Deloitte’s 2026 Global Human Capital Trends research reveals that while 60% of executives are already […]
At their best, Boards can be a founder's most valuable asset, providing the right level of accountability, invaluable strategic advice, and connections that lead directly to new knowledge, revenue, or talent. But at their worst, Boards can create distraction and overhead, apply unhealthy pressure, or even become an impediment to the company's success. In this […]
We are excited to host an invite-only Biotech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow biotech investors over lunch and engage in insightful conversations. Thank you to Seward & Kissel & Dean Dorton for sponsoring this lunch!